arrow
Y

Yien Ning Sophia Wong

national cancer centre singapore
H指数:29
被引数:7,656

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma

基于人工智能的模型ANORAK改善肺腺癌的组织病理学分级

2024-01-102
OAAI
Body composition and lung cancer-associated cachexia in TRACERx

TRACERx中的身体成分和肺癌相关的恶病质

2023-04-1233
OAAI
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

TRACERx中肺腺癌形态学的进化特征

2023-04-1231
OAAI
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
2021-09-023
OAAI
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

系统性促炎反应可确定患有SARS-CoV-2感染不良后果的癌症患者: OnCovid炎症评分

2021-03-2225
OAAI
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

欧洲癌症患者SARS-CoV-2流行的临床肖像

2020-10-01147
OAAI
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer (vol 25, pg1549, 2019)

T细胞受体库的空间异质性反映了肺癌的突变情况 (第25卷,pg1549,2019)

2020-06-033
OAAI
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
2020-05-2274
OA
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
2019-10-07145
OAAI
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment
2018-09-2644
OAAI
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
IMMUNITY
IF26.3
2017-04-01368
OAAI